Page 385 - SRL Diagnostics

SR # TEST NAME TAT

190 Spastic Paraplegia NGS Panel 58 genes 8 WEEKS
191 Squamous Cell Carcinoma Ag 7 - 10 DAYS
192 Steroid-Resistant Nephrotic Syndrome 14-gene 6 - 8 WEEKS
panel
193 Steroid-Resistant Nephrotic Syndrome 14-gene 6 - 8 WEEKS
panel (ACTN4, CD2AP, COQ2, INF2, LAMB2,
LMX1B, NPHS1, NPHS2, PDSS2, PLCE1,
SCARB2, SMARCAL1, TRPC6, WT1)
194 Strontium, Blood 10 DAYS
195 Strontium, Serum/Plasma 10 DAYS
196 Strontium, Urine 10 DAYS
197 Substance P 7 - 10 DAYS
198 SUCLA2 Gene 8 WEEKS
199 Superoxide dismutase (SOD) 10 DAYS
200 TCN2 gene associated with Transcobalamin II 8 WEEKS
Deficiency
201 Testosterone, Saliva 2 WEEKS
202 Titin Abs 7 - 10 DAYS
203 Tocopherol (Vitamin E) 5 - 7 DAYS
204 TRAPS 6 WEEKS
205 Tropheryma whipplei PCR 7 - 10 DAYS
206 Type 1 Neurofibromatosis testing involves full 8 WEEKS
sequencing + deletion/duplication testing for the
NF1 + SPRED1 genes
207 Type 2 (NF2-related) Neurofibromatosis is less 8 WEEKS
common and usually has bilateral vestibular
schwannomas and acoustic involvement
(impaired hearing). Sequencing + deletion/du-
plication testing for the NF2 gene
208 UROD Gene 4 - 6 WEEKS
209 Vitamin C/ Ascorbic Acid 7 - 10 DAYS
210 Voltage-Gated Potassium Channel (VGKC) 15 DAYS
Antibody
211 Whole exome sequencing (80-100x), Offered as 12 WEEKS
a family trio (one price, three samples – to
include affected child + parents. Additional
affected children can be added for free).
212 Whole Genome Sequencing 12 WEEKS
213 William syndrome 7 - 10 DAYS
214 Zinc-Protoporphyrin in RBC (HPLC) 5 - 7 DAYS
215 α-Subunit, Free 10 DAYS